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1  | INTRODUC TION
Currently, renal transplantation is the treatment of choice in pa-
tients with end- stage renal disease. Compared to dialysis, renal 
transplantation improves quality of life and survival, against lower 
medical costs.1,2 The number of kidneys available for transplanta-
tion is limited and there is a growing discrepancy between supply 
and demand in organ transplantation.3 Therefore, it is of major im-
portance to optimize graft survival. Furthermore, patient survival of 
renal transplant recipients (RTR) is significantly lower compared to 
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Renal transplant recipients (RTR) are at risk of decline of graft function and prema-
ture mortality, with high blood pressure as an important risk factor for both. To study 
the	 association	 of	 the	 Dietary	 Approach	 to	 Stop	 Hypertension	 (DASH)	 diet	 with	
these adverse events, we conducted a prospective cohort study of adult RTR. Dietary 
data were collected using a validated 177- item food frequency questionnaire and an 
overall	DASH-	score	was	obtained.	We	 included	632	 stable	RTR	 (mean	±	standard	
deviation	age	53.0	±	12.7	years,	57%	men).	Mean	DASH	score	was	23.8	±	4.7.	During	
median	 follow-	up	 of	 5.3	 (interquartile	 range,	 4.1-	6.0)	years,	 119	 (18.8%)	 RTR	 had	
renal function decline, defined as a combined endpoint of doubling of serum creati-
nine	and	death-	censored	graft	failure,	and	128	(20.3%)	died.	In	Cox-	regression	analy-
ses,	RTR	in	the	highest	tertile	of	the	DASH	score	had	lower	risk	of	both	renal	function	
decline	 (hazard	 ratio	 [HR]	=	0.57;	95%	confidence	 interval	 [CI],	 0.33-	0.96,	P	=	.03)	
and	all-	cause	mortality	(HR	=	0.52;	95%CI,	0.32-	0.83,	P	=	.006)	compared	to	the	low-
est	tertile,	independent	of	potential	confounders.	Adherence	to	a	DASH-	style	diet	is	
associated with lower risk of both renal function decline and all- cause mortality. 
These results suggest that a healthful diet might benefit long- term outcome in RTR.
K E Y W O R D S
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the general population.4 In spite of previous developments, in the 
past 2 decades, there was only little improvement in long- term graft 
and patient survival after renal transplantation.5	Approximately	50%	
of all renal allografts from deceased donors are lost in a period of 10- 
12 years after transplantation.6	As	a	result	of	this	stagnation,	there	
is a growing interest in other factors that may influence graft and 
patient survival after renal transplantation, such as diet and other 
lifestyle factors.
Previous studies on diet often focused on single nutrients, but 
currently there is a growing interest in dietary patterns, since they 
can take into account complex interactions and are easier to inter-
pret. Dietary patterns can directly be translated into dietary recom-
mendations to be used in clinical practice.7,8 Previously, we found 
that a Mediterranean- style diet is associated with a lower risk of 
new- onset diabetes and all- cause mortality after renal transplanta-
tion.9 In contrast to the Mediterranean diet, which is based on a diet 
traditionally consumed by the inhabitants of regions surrounding the 
Mediterranean	sea,	 the	Dietary	Approaches	 to	Stop	Hypertension	
(DASH)	diet	features	a	high	intake	of	fruits,	vegetables,	whole	grains	
(complex carbohydrates), low- fat dairy products, legumes and nuts, 
and a low intake of sodium, sweetened beverages, and red pro-
cessed meat.10,11
Originally,	the	DASH	diet	was	developed	to	reduce	blood	pres-
sure, and considering that hypertension is associated with graft fail-
ure12-14 and mortality in RTR,15	the	DASH	diet	might	greatly	benefit	
RTR.	Yet,	 it	has	never	been	investigated	whether	the	DASH	diet	is	
associated with graft and patient survival after renal transplantation. 
We	hypothesized	that	the	DASH	diet	is	associated	with	a	lower	risk	
of renal function decline and all- cause mortality.
2  | SUBJEC TS AND METHODS
2.1 | Study population
This observational prospective cohort study was conducted in 
a large single- center prospective cohort of RTR.16,17	 Adult	 RTR	
(≥18	years)	with	a	functioning	graft	 for	at	 least	1	year	and	no	his-
tory of alcohol and/or drug addiction were included. Furthermore, 
at inclusion, RTR in this study had no known or apparent systemic 
diseases, such as malignancies or active infections. Between 
November 2008 and May 2011, patients who visited the outpa-
tient	 clinic	 of	 the	 University	 Medical	 Center	 Groningen	 (UMCG)	
were invited to participate. Of the initial 817 invited patients, 707 
(86.5%)	signed	written	informed	consent.	The	study	was	observa-
tional in nature and no study based protocols were applied to moni-
tor	the	adherence	of	patients	to	healthy	dietary	lifestyles.	As	part	
of our routine, patients receive 1 consult of a dietitian, who pro-
vides  advice about a healthy diet, with special attention to sodium 
 restriction. For our study, we excluded patients with missing dietary 
data	 (n	=	75),	 leaving	632	RTR	eligible	 for	analyses	 (Supplemental	




All	 baseline	measurements	were	 performed	 once	 at	 baseline	 dur-
ing a morning visit to the outpatient clinic as described previously.18 
Body weight and height were measured, and body mass index (BMI) 
was calculated as weight divided by height squared (kg/m2).	A	semi-
automatic device (Dinamap®1846;	Critikon,	Tampa,	FL)	was	used	to	
measure blood pressure and heart rate every minute for 15 minutes 
in a half- sitting position. The average of the last 3 measurements was 
taken as the blood pressure value. Information on medication was 
derived from patient records, whereas information on smoking be-
havior was obtained by a questionnaire. Information on physical ac-
tivity was obtained using the reliable and valid Short Questionnaire 
to	Assess	Health	enhancing	physical	activity	score	in	time	multiplied	
by intensity.19 Blood was drawn after an 8- 12- hour overnight fasting 
period in the morning after completion of 24- hour urine collection. 
RTR were instructed to assure adequate urine collection. They were 
instructed to discard their first morning urine specimen and then 
collect their urine for the next 24 hours, including the next morning’s 
first specimen of the day of their visit. The serum creatinine- based 
Chronic Kidney Disease Epidemiology Collaboration equation20 was 
used	to	calculate	the	estimated	glomerular	filtration	rate	(eGFR).
2.3 | Dietary intake assessment
A	 semiquantitative	 food	 frequency	 questionnaire	 (FFQ)	 was	 used	
to obtain information on dietary intake during the last month, tak-
ing into account seasonal variations. The FFQ was developed at 
Wageningen	University,	 consisted	of	177	 items,	was	 reproducible,	
biomarker validated,21,22 and updated several times. The frequency 
of each of the food items was recorded in times per day, week, or 
month. Expression of number of servings was in either natural units, 
such as a slice of bread or an apple, or in household measures, for 
example, a cup or a teaspoon. Subsequently, all dietary data were 
converted into total energy and nutrient intake per day using the 
Dutch	 Food	 Composition	 Table	 (NEVO	 2006).	 The	 FFQ	was	 vali-
dated by comparing the protein intake of the FFQ with the protein 




is based on 8 recommendations: high intake of fruits, vegetables, 
legumes and nuts, whole grains, low- fat dairy products and low 
intake of sodium, red and processed meats, and sugar- sweetened 
beverages (Supplemental Table S1). Sodium intake was determined 
based on 24- hour urinary sodium excretion, which is considered the 
criterion standard to assess daily sodium intake.23 For each of the 
components, subjects were classified into sex- specific quintiles ac-
cording to their intake. For each of the components (fruit, vegeta-
bles, legumes and nuts, whole grains and low- fat dairy products), a 
score ranging from 1 to 5 was attributed to the participants (1 for the 
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lowest quintile and 5 for the highest quintile). For the components 
sodium, red and processed meats, and sugar- sweetened beverages 
the scoring was reversed (5 points for the lowest quintile and 1 for 
the highest quintile). The component scores were summed up to ob-
tain	an	overall	DASH	score	ranging	from	8	(lowest	adherence)	to	40	
(highest adherence). Subsequently, we divided all patients in tertiles 
of	the	overall	DASH	score.
2.5 | Clinical endpoints
The primary outcomes of this study are renal function decline and 
all- cause mortality. Renal function decline was defined as doubling 
of serum creatinine and/or death- censored graft failure. Doubling of 
serum creatinine concentration, defined as the first serum creatinine 
value that was twice the baseline value, has been used frequently in 
several clinical nephrology trials to study renal function decline.24-26 
Death- censored graft failure was defined as return to hemodialysis 
treatment or retransplantation. Data on serum creatinine, death- 
censored graft failure, and all- cause mortality after baseline were 
retrieved from patient files until the end of September 2015. Since 
the outpatient program uses continuous surveillance systems, it 
guarantees correct and up- to- date information on patient status. No 
participants were lost to follow- up.
2.6 | Statistical analyses
With	use	of	histograms	and	probability	(Q-	Q)	plots,	we	tested	vari-
able distribution. For descriptive statistics, data are presented as 
mean and standard deviation when normally distributed, as median 
and interquartile range when skewed distributed, and as number 
and percentage in case of categorical data. Differences between the 
tertiles were compared using 1- way analysis of variance tests for 
normally	distributed,	continuous	variables,	Kruskal-	Wallis	 tests	 for	
skewed distributed, continuous variables and χ2 tests for categorical 
variables.
We	 performed	multivariable	 Cox	 proportional	 hazards	 regres-
sion	analyses	to	estimate	the	effect	of	the	DASH	diet	on	renal	func-
tion decline and all- cause mortality. First we performed analyses 
adjusted	for	age	and	sex	(model	1).	We	further	cumulatively	adjusted	
for	 kidney	 function	 parameters	 (eGFR,	 proteinuria,	 time	 between	
transplantation and baseline, and primary renal disease) in model 
2.	We	 continued	with	 cumulative	 adjustment	 for	 transplant	 char-
acteristics (acute rejection, pre- emptive transplantation, and donor 
type) in model 3. Since Cox proportional hazards regression mod-
els should not contain more than 10 events per variable,27 we per-
formed further adjustments for potential confounders in additional 
models	based	on	model	3.	We	additionally	adjusted	for	dietary	and	
lifestyle factors (smoking, alcohol consumption, total kcal intake, and 
physical activity) in model 4; use of immunosuppressive medication 
(calcineurin inhibitors and prednisolone), trough levels of tacrolimus 
and cyclosporine, and coefficients of variation (standard deviation/
mean	×	100%)	of	calcineurin	levels	between	half	a	year	before	base-
line to 1 year after baseline in model 5; systolic blood pressure and 
use	of	antihypertensive	drugs	in	model	6;	BMI	in	model	7;	and	low-	
density lipoprotein (LDL)–cholesterol and total cholesterol in model 
8.	The	DASH	score	was	used	as	both	continuous	variable	and	as	cat-
egorical variable. Patients were censored at date of last follow- up or 
death.	Hazards	ratios	and	95%	confidence	intervals	(CIs)	were	given	
for the Cox proportional hazards analyses. Schoenfeld residuals of 
the	DASH	score	were	checked	and	tested	in	STATA	using	the	pro-
portional	hazard	test	by	Grambsch	and	Therneau.28 The assumption 
of proportional hazards was not violated. Penalized splines were 
constructed	to	visualize	the	association	of	the	DASH	score	on	renal	
function decline and all- cause mortality after adjustment for age and 
sex.
To study the association of the individual components of the 
DASH	diet	and	 the	endpoints,	we	calculated	 the	median	 intake	of	
the components in g/d. For all components, we compared an intake 
above the median with an intake below the median.
In addition, we evaluated potential effect modification by age, 
sex,	 systolic	 blood	pressure	 (SBP),	 baseline	eGFR,	 smoking	 status,	
alcohol consumption, and physical activity. Potential effect modifi-
ers were tested by entering both main effects and the cross- product 
term	in	Cox	regression	analyses.	When	effect	modification	was	ob-
served, we proceeded with Cox regression analyses in subgroups of 
RTR	stratified	by	the	observed	effect	modifier.	We	performed	com-
peting risk analyses (as sensitivity analyses) according to Fine and 
Gray.29
All	 P	 values	 were	 2-	tailed.	 A	 P	≤	.05	 was	 considered	 statisti-
cally	significant.	All	statistical	data	analyses	were	performed	using	
IBM	 Statistics	 SPSS	 version	 23.0	 (IBM	 Inc.,	 Chicago,	 IL),	 STATA	





Mean	 age	 of	 RTR	 was	 53.0	±	12.7	years	 and	 56.5%	 of	 the	
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TABLE  1 Baseline	characteristics	of	the	overall	RTR	population	and	according	to	tertiles	based	on	the	DASH	score
DASH score
Overall RTR Tertiles of DASH score
P
23.8 18.5 24.0 29.3
(n = 632) (n = 206) (n = 238) (n = 188)
Background variables
Age,	y 53.0	±	12.7 49.5	±	13.3 52.8	±	12.3 57.0	±	11.3 <.001
Male	sex,	n	(%) 357	(56.5) 146	(70.9) 126	(52.9) 85 (45.2) <.001
Current	smokers,	n	(%) 77 (12.2) 39	(18.9) 22	(9.2) 16	(8.5) .001
Alcohol	consumption,	g/d 2.6	(0.0-	11.1) 3.8 (0.0- 14.7) 2.5 (0.0- 8.7) 1.6	(0.0-	9.7) .10
Total energy intake, kcal/d 2175	±	639 2151	±	667 2221	±	667 2144	±	567 .38
Physical activity score 
(time × intensity)
5245	(2498-	8029) 5460	(1943-	8400) 5050	(2100-	8093) 5280	(2798-	7435) .71
Weight,	kg 80.3	±	16.5 83.4	±	17.8 81.0	±	16.7 76.0	±	13.9 <.001
BMI, kg/m2 26.6	±	4.8 27.2	±	5.0 27.0	±	4.8 25.6	±	4.3 .001
eGFR,	mL/min	per	1.73	m2 52.5	±	20.1 52.7	±	20.4 52.5	±	20.6 52.2	±	19.3 .97
Circulation
Heart	rate,	bpm 68.8	±	12.1 67.7	±	12.1 70.2	±	11.9 68.1	±	12.2 .07
SBP,	mm	Hg 136.2	±	17.4 137.7	±	18.3 137.6	±	17.7 132.7	±	15.3 .005
DBP,	mm	Hg 82.9	±	11.0 85.2	±	11.2 83.4	±	11.1 79.9	±	9.8 <.001
MAP,	mm	Hg 100.7	±	12.0 102.7	±	12.7 101.5	±	12.2 97.5	±	10.4 <.001
Laboratory parameters
Triglycerides, mmol/L 1.7 (1.2- 2.3) 1.7	(1.2-	2.6) 1.8 (1.3- 2.2) 1.5 (1.1- 2.1) .02
Total cholesterol, mmol/L 5.1	±	1.1 5.2	±	1.2 5.1	±	1.1 5.1	±	1.1 .20
HDL-	cholesterol,	mmol/L 1.4	±	0.5 1.3	±	0.4 1.4	±	0.5 1.5	±	0.5 .03
LDL- cholesterol, mmol/L 3.0	±	0.9 3.1	±	1.0 3.0	±	0.9 2.9	±	0.9 .35
C- reactive protein, mg/dL 1.6	(0.7-	4.5) 1.8	(0.6-	5.0) 1.6	(0.8-	4.5) 1.5 (0.5- 3.8) .44
Fasting glucose, mmol/L 5.3	(4.8-	6.0) 5.3	(4.8-	6.2) 5.2	(4.8-	6.1) 5.2 (4.7- 5.8) .43
HbA1C,	% 6.0	±	0.8 6.0	±	0.8 6.0	±	0.8 6.0	±	0.8 .91
Urinary parameters
Sodium excretion, mmol/24 h 157.2	±	61.1 189.1	±	66.0 153.9	±	53.0 126.5	±	46.9 <.001
Potassium excretion, mmol/24 h 73.2	±	24.3 72.0	±	24.6 71.0	±	23.6 77.2	±	24.6 .02
Creatinine excretion, mmol/24 h 11.7	±	3.4 12.8	±	3.4 11.6	±	3.5 10.4	±	2.7 <.001
Urea excretion, mmol/24 h 391.3	±	114.7 410.4	±	124.5 384.3	±	111.1 379.3	±	105.5 .01
Albumin	excretion,	mg/24	h 260.9	±	676.5 352.5	±	826.8 256.6	±	699.8 166.7	±	397.6 .03
Proteinuria,	n	(%) 139	(22.0) 59	(28.6) 55 (23.1) 25 (13.3) .001
Primary renal disease .83
Primary	glomerulosclerosis,	n	(%) 180 (28.5) 63	(30.6) 66	(27.7) 51 (27.1)
Glomerulonephritis,	n	(%) 46	(7.3) 18 (8.7) 16	(6.7) 12	(6.4)
Tubulointerstitial	nephritis,	n	(%) 74 (11.7) 27 (13.1) 25 (10.5) 22 (11.7)
Polycystic	kidney	disease,	n	(%) 135 (21.4) 37 (18.0) 56	(23.5) 42 (22.3)
Renal	hypodysplasia,	n	(%) 23	(3.6) 9	(4.4) 10 (4.2) 4 (2.1)
Renovascular	diseases,	n	(%) 35 (5.5) 14	(6.8) 12 (5.0) 9	(4.8)
Diabetes	mellitus,	n	(%) 30 (4.7) 9	(4.4) 12 (5.0) 9	(4.8)
Other,	n	(%) 109	(17.2) 29	(14.1) 41 (17.2) 39	(20.7)
Transplant characteristics
Transplant vintage, y 5.7	(1.9-	12.1) 5.0 (1.7- 11.3) 5.7	(1.9-	11.0) 7.0 (2.1- 14.4) .09
Living	donor,	n	(%) 216	(34.2) 71 (34.5) 81 (34.0) 64	(34.0) .99
(Continues)
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transplantation	was	5.7	(interquartile	range	[IQR],	1.9-	12.1)	years.	
The	DASH	 score	 varied	 between	 12	 (lowest	 adherence)	 and	 37	
(highest	 adherence),	 with	 a	 mean	 score	 of	 23.8	±	4.7	 (Figure	1).	
Baseline characteristics of the overall RTR population and accord-
ing	to	tertiles	based	on	the	sex-	specific	DASH	score	are	shown	in	
Table	1.	RTR	with	a	high	adherence	to	the	DASH	diet	were	older,	
more often female, more frequently nonsmokers, and had a lower 
BMI	 compared	 to	 patients	 with	 a	 low	 adherence	 to	 the	 DASH	
diet.	Furthermore,	RTR	with	a	high	DASH	score	had	a	lower	blood	
pressure, lower fasting triglycerides, and higher high- density lipo-
protein	 (HDL)–cholesterol	 concentrations.	Moreover,	RTR	 in	 the	
tertile	with	the	highest	DASH	score	had	lower	24-	hour	urinary	so-
dium, higher 24- hour potassium, and lower 24- hour urea excretion 
levels, and less proteinuria when compared to RTR in the tertile 
with	the	lowest	DASH	score.
3.2 | DASH score and renal function decline
During	median	follow-	up	of	5.3	 (IQR,	4.1-	6.0)	years,	119	 (18.8%)	




adjusted	 for	 age	 and	 sex	 (Table	2).	 Adjustment	 for	 other	 poten-
tial confounders, including kidney function parameters, trans-
plant characteristics, and dietary and lifestyle factors, did not 
materially	change	 the	association.	We	proceeded	with	multivari-
able Cox proportional hazards models for analyses of tertiles of 
the	DASH	score.	RTR	 in	 the	highest	 tertile	had	>50%	 lower	 risk	
of	renal	function	decline	(HR	=	0.46,	95%	CI,	0.28-	0.76,	P	=	.002)	
when compared to the lowest tertile, independent of age and sex. 
DASH score
Overall RTR Tertiles of DASH score
P
23.8 18.5 24.0 29.3
(n = 632) (n = 206) (n = 238) (n = 188)
Pre-	emptive	transplant,	n	(%) 103	(16.3) 32 (15.5) 41 (17.2) 30	(16.0) .88
Dialysis duration, mo 36.0	(20.0-	59.0) 43.0	(13.5-	60.0) 42.0	(30.0-	66.0) 32.0	(16.0-	50.0) .17
Age	donor,	y 43.1	±	15.5 42.4	±	15.7 42.5	±	15.6 44.6	±	15.0 .29
Cold ischemia time, h 14.2	(2.6-	20.8) 14.3 (2.7- 20.0) 13.06	(2.60-	20.81) 15.2	(2.6-	21.1) .76
Warm	ischemia	time,	min 40.0 (33.0- 50.0) 41.0 (33.5- 50.0) 40.0	(33.0-	49.5) 40.0 (33.0- 50.0) .70
Acute	rejection,	n	(%) 166	(26.3) 52 (25.2) 63	(26.5) 51 (27.1) .91
Medication
Calcineurin	inhibitor,	n	(%) .36
Cyclosporine 250	(39.6) 80 (38.8) 99	(41.6) 71 (37.8)
Tacrolimus 110 (17.4) 40	(19.4) 44 (18.5) 26	(13.8)
Cyclosporine (trough level, μg/L) 107.0 (77.0- 150.0) 110.0	(77.0-	149.0) 97.5	(75.0-	140.3) 116.0	(77.3-	157.8) .52
Tacrolimus (trough level, μg/L) 7.1	(5.4-	9.1) 6.7	(5.2-	8.4) 7.7	(6.1-	10.9) 6.6	(4.8-	9.4) .22
CV	of	CCNI	trough	levels	(%) 26.6	(17.0-	47.0) 29.1	(18.6-	45.0) 23.9	(17.4-	46.7) 27.0 (14.7- 50.0) .45
Proliferation	inhibitor,	n	(%) .29
Azathioprine 111	(17.6) 36	(17.5) 35 (14.7) 40 (21.3)
Mycophenolate 418	(66.1) 132	(64.1) 162	(68.1) 124	(66.0)
mTOR	inhibitor,	n	(%) 10	(1.6) 4	(1.9) 2 (0.8) 4 (2.1) .52
Prednisolone dose, mg 10.0 (7.5- 10.0) 10.0 (7.5- 10.0) 10.0 (7.5- 10.0) 10.0 (7.5- 10.0) .27
Diuretics,	n	(%) 257 (40.7) 88 (42.7) 96	(40.3) 73 (38.8) .73
β-	Blocker,	n	(%) 400	(63.3) 126	(61.2) 152	(63.9) 122	(64.9) .73
ACE	inhibitor,	n	(%) 207 (32.8) 78	(37.9) 75 (31.5) 54 (28.7) .14
Angiotensin	II	receptor	blocker,	n	(%) 102	(16.1) 31 (15.0) 40	(16.8) 31	(16.5) .87
Calcium	antagonist,	n	(%) 156	(24.7) 60	(29.1) 59	(24.8) 37	(19.7) .09




recipients; SBP, systolic blood pressure.
Data	are	represented	as	mean	±	SD,	median	(interquartile	range),	or	n	(%).	Differences	were	tested	by	analysis	of	variance	or	Kruskal-	Wallis	for	contin-
uous variables and with χ2 test for categorical variables.
TABLE  1  (Continued)
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After	 adjustment	 for	 kidney	 function	 parameters	 and	 transplant	
characteristics,	 the	 association	 remained	 significant	 (HR	=	0.57;	
95%	CI,	 0.33-	0.96,	P	=	.03).	 The	 association	 remained	materially	
unchanged after further adjustment for other potential confound-
ers	(Table	2,	models	4-	7).	To	illustrate	the	association	of	the	DASH	
score and renal function decline, an age- and sex- adjusted penal-
ized spline is shown in Figure 2.
3.3 | DASH score and all- cause mortality
We	 continued	 with	 analyses	 for	 the	 association	 of	 the	 DASH	
score	 on	 all-	cause	 mortality.	 During	 follow-	up,	 128	 (20.3%)	
died.	Cox	regression	analyses	with	the	DASH	score	analyzed	as	
continuous	 variable	 showed	 that	 a	higher	DASH	score	was	 as-
sociated	with	a	lower	risk	of	all-	cause	mortality	(HR	=	0.95;	95%	
CI,	0.91-	0.99,	P	=	.01),	when	adjusted	for	age	and	sex	(Table	2).	
Adjustment	 for	 other	 potential	 confounders	 did	 not	 materi-
ally	 change	 the	 association.	 We	 proceeded	 with	 multivariable	
Cox proportional hazards models for analyses of tertiles of the 
DASH	score.	RTR	 in	 the	highest	 tertile	had	>50%	 lower	 risk	of	
all-	cause	 mortality	 (HR	=	0.48,	 95%	 CI,	 0.30-	0.77,	 P	=	.002)	
when compared to the lowest tertile, independent of age and 
sex.	Adjustment	for	other	potential	confounders,	including	kid-
ney function parameters and transplant characteristics, did not 
materially	 change	 the	 results	 (HR	=	0.52;	 95%	 CI,	 0.32-	0.83,	
P	=	.006).	The	association	remained	materially	unchanged	after	
TABLE  2 Association	of	the	DASH	score	with	renal	function	decline	and	all-	cause	mortality
DASH score as continuous 
variable
Tertiles of DASH score
T1 T2 T3
HR (95% CI) P value Reference HR (95% CI) P value HR (95% CI) P value
Renal function decline
No. of events 119 53 42 24
Model 1 0.95	(0.91-	0.99) .008 1.00 0.65	(0.43-	0.98) .04 0.46	(0.28-	0.76) .002
Model 2 0.95	(0.91-	0.99) .03 1.00 0.67	(0.44-	1.02) .06 0.54	(0.32-	0.91) .02
Model 3 0.96	(0.92-	1.00) .08 1.00 0.72 (0.47- 1.10) .13 0.57	(0.33-	0.96) .03
Model 4 0.96	(0.91-	1.00) .05 1.00 0.70 (0.45- 1.10) .12 0.57	(0.33-	0.97) .04
Model 5 0.96	(0.92-	1.00) .08 1.00 0.75	(0.48-	1.16) .19 0.56	(0.33-	0.95) .03
Model	6 0.96	(0.91-	1.00) .05 1.00 0.72 (0.47- 1.10) .13 0.54	(0.32-	0.93) .03
Model 7 0.96	(0.91-	1.00) .05 1.00 0.70	(0.46-	1.07) .10 0.53	(0.31-	0.91) .02
Model 8 0.95	(0.91-	0.99) .03 1.00 0.66	(0.42-	1.01) .06 0.52 (0.30- 0.88) .02
All-	cause	mortality
No. of events 128 47 48 33
Model 1 0.95	(0.91-	0.99) .01 1.00 0.68	(0.45-	1.03) .07 0.48 (0.30- 0.77) .002
Model 2 0.95	(0.91-	0.99) .01 1.00 0.68	(0.45-	1.04) .07 0.50 (0.31- 0.80) .004
Model 3 0.95	(0.92-	0.99) .02 1.00 0.70	(0.46-	1.05) .09 0.52 (0.32- 0.83) .006
Model 4 0.96	(0.92-	1.00) .03 1.00 0.71 (0.45- 1.10) .13 0.53	(0.32-	0.86) .01
Model 5 0.96	(0.92-	0.99) .03 1.00 0.70	(0.46-	1.08) .11 0.51 (0.31- 0.82) .005
Model	6 0.95	(0.91-	0.99) .01 1.00 0.70	(0.46-	1.07) .10 0.49	(0.30-	0.79) .003
Model 7 0.95	(0.91-	0.99) .02 1.00 0.70	(0.46	-	1.06) .09 0.49	(0.30-	0.79) .004
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further adjustment for other potential confounders (Table 2, 
models	4-	7).	To	illustrate	the	association	of	the	DASH	score	and	
all- cause mortality, an age- and sex- adjusted penalized spline is 
shown in Figure 2.
3.4 | Individual components of the DASH score
The	 association	 of	 the	 individual	 components	 of	 the	DASH	 score	
on renal function decline and all- cause mortality, adjusted for age, 
sex, kidney function parameters, and transplant characteristics are 
shown	in	Table	3.	A	higher	intake	of	fruit	was	associated	with	a	lower	
risk	of	renal	function	decline	(HR	=	0.65;	95%	CI,	0.44-	0.95,	P	=	.03)	
and	 all-	cause	 mortality	 (HR	=	0.68;	 95%	 CI,	 0.48-	0.98,	 P	=	.04).	




We	 observed	 that	 the	 association	 of	 the	 DASH	 score	 with	 renal	
function	 decline	 was	 modified	 by	 baseline	 eGFR	 (Pinteraction	=	.005)	
and smoking behavior (Pinteraction	=	.01),	 independent	 of	 age	 and	 sex	
(Figure	3).	The	association	of	the	DASH	score	with	all-	cause	mortality	
was	only	modified	by	baseline	eGFR	 (Pinteraction	=	.002),	 independent	
of age and sex (Figure 4). No further evidence was found for effect 
modification by sex, SBP, smoking behavior, alcohol consumption, and 
physical activity (Pinteraction	≥	.05).	Higher	adherence	to	the	DASH	score	
was associated with a lower risk of renal function decline and all- cause 
mortality	 in	 the	 subgroup	 of	 RTR	with	 higher	 eGFR	 (eGFR≥45	mL/
min per 1.73 m2),	 but	not	 in	 the	 subgroup	of	RTR	with	 lower	eGFR	
(eGFR<45	mL/min	per	1.73	m2). Furthermore, higher adherence to the 
DASH	score	was	associated	with	a	lower	risk	of	renal	function	decline	





transplant recipients. Data were fit by a 
Cox regression model based on penalized 




Renal function decline All- cause mortality
Low intake High intake Low intake High intake
Components Median (g/d) Reference HR (95% CI) Reference HR (95% CI)
Fruits 123.00 1.00 0.65	(0.44-	0.95) 1.00 0.68	(0.48-	0.98)
Vegetables 80.06 1.00 0.77 (0.53- 1.13) 1.00 0.87	(0.61-	1.24)
Legumes and nuts 36.93 1.00 0.75	(0.51-	1.09) 1.00 0.93	(0.65-	1.33)
Whole	grains 102.00 1.00 0.77 (0.53- 1.14) 1.00 0.75	(0.52-	1.09)
Low- fat dairy products 232.86 1.00 1.06	(0.74-	1.54) 1.00 0.74	(0.52-	1.06)
Sodium 3.40 1.00 0.94	(0.63-	1.40) 1.00 0.76	(0.52-	1.11)
Red processed meat 67.98 1.00 1.02 (0.71- 1.48) 1.00 0.81	(0.57-	1.16)
SSB 154.47 1.00 0.97	(0.66-	1.42) 1.00 1.52	(1.06-	2.19)
CI,	confidence	interval;	DASH,	Dietary	Approach	to	Stop	Hypertension;	eGFR,	estimated	glomerular	filtration	rate;	HR,	hazard	ratio;	RTR,	renal	trans-




istics (acute rejection, pre- emptive transplantation, and donor type).
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3.6 | Sensitivity analyses
The results of competing risk analyses did not materially differ from 
those	with	Cox	 regression,	with,	 for	 example,	 a	HR	of	0.48	 (95%	CI,	
0.29-	0.79)	for	the	association	of	the	highest	tertile	of	DASH	score	with	
renal function decline compared to the lowest tertile in model 1 with ad-
justment	for	age	and	sex	(Table	2	for	comparison)	and	a	HR	of	0.59	(95%	
CI,	0.35-	0.99)	in	model	3	with	adjustment	for	age,	sex,	kidney	function	
parameters, and transplant characteristics (Table 2 for comparison).
4  | DISCUSSION
This	 study	 showed	 that	high	adherence	 to	 a	DASH-	style	diet	was	
associated with a lower risk of renal function decline and all- cause 
mortality in RTR. In addition, these associations were modified by 
baseline	eGFR,	and	for	 the	association	with	renal	 function	decline	
also by smoking behavior.




women.30 Moreover, in a cross- sectional study among the urban 
poor	in	the	United	States,	low	adherence	to	the	DASH	diet	was	asso-
ciated with a higher risk of chronic kidney disease (CKD).31	A	recent	
prospective	 study	 showed	 that	 high	 adherence	 to	 the	DASH	 diet	
was inversely associated with prevalence of CKD in an Iranian pop-
ulation.32	Not	only	is	the	DASH	diet	associated	with	a	lower	risk	of	
renal failure in the general population, but also high adherence to the 
DASH	diet	 is	associated	with	 lower	mortality	rates	 in	women	with	
heart failure33 and adults with hypertension.34 To the best of our 
knowledge,	the	DASH	diet	has	not	previously	been	studied	in	RTR.
F IGURE  3 Stratified analyses of the 
association	of	the	DASH	score	on	renal	
function decline in RTR adjusted for age 
and sex. Subgroups with P < .05 were 
considered effect modifiers. BMI, body 
mass	index;	DASH,	Dietary	Approach	
to	Stop	Hypertension;	eGFR,	estimated	
glomerular filtration rate; RTR, renal 
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F IGURE  4 Stratified analyses of the 
association	of	the	DASH	score	on	all-	
cause mortality in RTR adjusted for age 
and sex. Subgroups with P < .05 were 
considered effect modifiers. BMI, body 
mass	index;	DASH,	Dietary	Approach	
to	Stop	Hypertension;	eGFR,	estimated	
glomerular filtration rate; RTR, renal 
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The	DASH	diet	consists	of	a	high	intake	of	fruit,	vegetables,	whole	
grains, low- fat dairy products, legumes and nuts, and a low intake of 




of renal function decline and all- cause mortality when compared to a 
low intake of fruit. Previous prospective cohort- studies showed that 
high intake of fruits, vegetables, and whole grains is inversely asso-
ciated with kidney function decline30 and all- cause mortality in the 
general population.35,36 For the consumption of fruit, this is in agree-
ment with our study, but not for the intake of vegetables and whole 
grains. Furthermore, we found that a high intake of sugar- sweetened 
beverages was associated with a higher risk of all- cause mortality, 




decline in kidney function is associated with a progressive increase 
in cardiovascular risk.38 In addition, in patients with impaired renal 
function, cardiovascular risk factors, including hypertension, dia-
betes, albuminuria, anemia, vascular stiffness, metabolic acidosis, 
and dyslipidemia are common.38,39 Moreover, these patients often 
deal with multimorbidity40; hence, they may not be able to benefit 
enough	from	only	high	adherence	to	the	DASH	diet.	In	our	study,	we	
also	 found	a	 significant	association	of	 the	DASH	diet	with	decline	
of	renal	function	in	smokers	and	not	 in	nonsmokers.	However,	the	
reliability of this finding is doubtful, since the number of smokers 
in this RTR population is relatively small. It is known that smoking 
after renal transplantation is a risk factor for both graft failure and 
all- cause mortality in RTR; however, past smoking is only a risk fac-
tor for all- cause mortality, but not for graft failure.41 Furthermore, 
smoking in living kidney donors is associated with reduced patient 
survival, but not with graft survival.42 Unfortunately, we could not 
take into account changes in smoking status beyond baseline and 
information on smoking status of RTR and donors before transplan-
tation, since these data were not available.
It	 is	 known	 that	 the	DASH	diet	 effectively	 lowers	 blood	pres-
sure.43 In line with this, we found significant cross- sectional inverse 
associations	of	DASH	score	with	 systolic	 blood	pressure,	 diastolic	
blood	pressure,	and	mean	arterial	pressure.	However,	 the	associa-
tion	 of	 the	DASH	 score	with	 both	 endpoints	 remained	 significant	




continued to have better- controlled blood pressure over time, which 
leaves	 the	possibility	 that	 the	beneficial	 effects	of	 the	DASH	diet	
are mediated by blood pressure. Previous studies showed that the 
DASH	diet	improves	the	lipid	profile	by	lowering	triglyceride	levels,	
total cholesterol, and LDL- cholesterol concentration.44-46 In the 
baseline characteristics of this study, we observe lower triglyceride 
levels	 and	higher	HDL	concentrations	 in	 the	highest	 tertile	 of	 the	
DASH	score	compared	to	the	lowest	tertile.	No	differences	in	LDL-	
cholesterol	and	total	cholesterol	concentrations	were	found.	After	
adjustment for total cholesterol and LDL- cholesterol, the association 
of	the	DASH	score	and	all	primary	and	secondary	endpoints	became	
stronger, again suggesting multiple mechanisms behind the benefi-
cial	effect	of	the	DASH	diet.	Additionally,	the	DASH	diet	affects	in-
flammation, since this dietary pattern reduces circulating C- reactive 
protein (CRP) concentrations.47,48	However,	the	DASH	diet	did	not	
affect other inflammatory biomarkers, such as tumor necrosis fac-
tor- α,	interleukin-	6,	and	adiponectin.47,48 Nevertheless, in our study 
we observed no difference in CRP concentrations between the ter-
tiles. Recently, a prospective study showed that posttransplant CRP 
concentrations are inversely associated with graft function after 
renal transplantation.49 This has also been noted in a prospective 
study, which concluded that high serum CRP concentrations were 
associated with impaired renal function and a higher risk of graft 
failure in RTR compared to low and intermittent serum CRP concen-
trations.50	Another	mechanism	could	be	the	antioxidant	properties	
of	several	components	of	the	DASH	diet,	such	as	fruits,	vegetables,	
and whole grains, which are rich in phytochemicals.51
Strengths of this study include the use of a reproducible and bio-
marker validated FFQ, and the availability of 24- hour urinary sodium 
excretion to assess salt intake. Since salt intake varies widely in both 
processed and home- cooked meals, it is difficult to quantify sodium 
intake using a FFQ.23	Another	strength	of	the	current	study	is	the	com-
plete follow- up. Furthermore, the clinical endpoints—decline of renal 
function and all- cause mortality—are very relevant in daily practice. 
There are also several limitations. First, this prospective cohort study 
is a single- center study, with a study population that consisted mainly 
of white people. Therefore, it is unclear whether our findings can be ex-
trapolated to other populations. It would be relevant to repeat our study 
in other patient populations. Furthermore, information on dietary intake 
was assessed at a single time point at baseline, which may not be an 
accurate reflection of diet longitudinally. It should, however, be noted 
that most epidemiological studies use single baseline measurements to 
investigate associations with long- term outcomes, which is likely to ad-
versely affect strengths of these associations with outcome and there-
fore likely leads to underestimation of associations between baseline 
measurements and long- term outcome rather than overestimation.52,53
In conclusion, this single- center study of stable RTR showed that 
high	adherence	to	a	DASH-	style	diet	is	associated	with	a	lower	risk	of	
both renal function decline and all- cause mortality. This study adds 
to the current evidence that a healthful dietary pattern, such as the 
DASH	diet,	could	offer	an	approach	to	prevent	renal	function	decline	
and	all-	cause	mortality	after	renal	transplantation.	However,	our	study	
is observational in nature, and therefore a randomized clinical trial is 
required	 to	 actually	 demonstrate	 that	 adherence	 to	 the	DASH	 diet	
positively affects long- term outcomes in renal transplant recipients.
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